Can CRISPR Stop Mosquitoes From Biting? A New Hope For India's Fight Against Malaria & Dengue
Imagine a world where mosquitoes can no longer bite you. No itchy rashes. No dengue. No malaria. Sounds like a sci-fi fantasy? Thanks to CRISPR gene-editing technology, this vision might not be far from reality.
In ground-breaking developments, scientists have found a way to genetically modify mosquitoes so they cannot pierce human skin—disabling their ability to bite, suck blood, or transmit deadly diseases.
But how does this work, and what does it mean for India—a country where mosquito-borne illnesses remain a serious public health threat?
Why Is CRISPR A Gamechanger?
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a powerful gene-editing tool that allows scientists to make precise cuts in DNA. Think of it as a molecular pair of scissors that can turn off certain genes or insert new ones.
In the case of mosquitoes, researchers have used CRISPR to disable key genes in female mosquitoes—the ones responsible for biting. By targeting a gene essential for the structure and function of their proboscis (the needle-like mouthpart they use to pierce skin), scientists have made it physically impossible for these mosquitoes to feed on blood.
Without access to blood meals, they cannot reproduce effectively, and more importantly, they cannot spread diseases like malaria or dengue.
Why Target Female Mosquitoes?
Only female mosquitoes bite humans because they need the proteins in blood to produce eggs. By stopping this process, CRISPR not only prevents biting but also breaks the reproductive cycle. One major gene scientists are targeting is the doublesex gene, which is crucial for female mosquito development. When this gene is disrupted, females become infertile or are physically unable to feed.
In lab conditions, this technique has shown incredible promise, especially against the Anopheles stephensi species, which is a major malaria vector in Indian urban regions.
What This Means for India
India bears a heavy burden of mosquito-borne diseases. According to the National Vector Borne Disease Control Programme (NVBDCP), India reported thousands of dengue, chikungunya, and malaria cases each year. States like Uttar Pradesh, Maharashtra, and West Bengal consistently top the charts in mosquito-related outbreaks. Urbanisation, waterlogging, and climate change have worsened the situation.
The Anopheles stephensi mosquito, which thrives in Indian cities, is particularly dangerous. It breeds in man-made water containers and has adapted to survive urban conditions. Targeting this species using CRISPR could be a game-changer for India's urban health landscape.
Challenges To Implementation
While the CRISPR mosquito technology sounds revolutionary, deploying it in India is not as simple as flipping a switch. Here's why:
Environmental Impact: Mosquitoes, although notorious, are part of the food chain. Birds, bats, and fish feed on them. Altering or reducing their population can have unintended ecological effects. India's biodiversity is delicate, and every introduction must be thoroughly assessed.
Regulatory Hurdles: Gene editing in the wild is a tightly regulated area. India's Genetic Engineering Appraisal Committee (GEAC) will need to evaluate and approve such projects. Public health authorities, environmental scientists, and ethicists must also weigh in.
Community Consent: Releasing gene-edited mosquitoes into the environment requires transparency and trust. Local communities must understand the technology and give consent, especially in rural and tribal areas.
Climate and Population Complexity: India's varied climate and high population density could influence how effectively CRISPR-modified mosquitoes perform. What works in a controlled lab may not hold up in crowded, humid city slums or remote forest villages.
Mosquito-Borne Diseases: A Persistent Indian Menace
India has battled mosquito-borne diseases for decades. Despite massive awareness drives, fogging operations, and vaccine rollouts, outbreaks remain common. Some quick stats:
Malaria: Though cases have declined, India still accounts for a significant portion of South-East Asia's malaria burden.
Dengue: In recent years, dengue has surged across urban areas, overwhelming hospitals during peak monsoon months.
Chikungunya & Japanese Encephalitis: Sporadic but deadly, these illnesses are endemic in parts of India and remain hard to control.
Traditional methods like insecticides, larvicidal oils, and netting have shown limited long-term impact. Moreover, mosquitoes are developing resistance to chemicals, making new approaches like CRISPR all the more urgent.
What's Next?
Scientists believe that deploying CRISPR mosquitoes at scale in India could take 10-20 years. Why the delay? Because before they are released into the wild, they must pass:
Rigorous environmental impact studies
Multi-phase regulatory approvals
Extensive community engagement efforts
Field trials under Indian climatic and population conditions
In the long run, CRISPR could work alongside vaccines, awareness programmes, and conventional mosquito control measures. It will not be a silver bullet—but it could be a powerful weapon in India's public health arsenal.
For a country like India, where mosquito-borne diseases continue to kill and hospitalise thousands, CRISPR offers hope.
top videos
View all
The buzz may not stop overnight—but the bite just might.
About the Author
News Desk
The News Desk is a team of passionate editors and writers who break and analyse the most important events unfolding in India and abroad. From live updates to exclusive reports to in-depth explainers, the Desk d...Read More
Get Latest Updates on Movies, Breaking News On India, World, Live Cricket Scores, And Stock Market Updates. Also Download the News18 App to stay updated!
tags :
CRISPR Local18 Mosquito-borne diseases
view comments
Location :
Hyderabad, India, India
First Published:
August 04, 2025, 15:55 IST
News explainers Can CRISPR Stop Mosquitoes From Biting? A New Hope For India's Fight Against Malaria & Dengue
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
an hour ago
- Hindustan Times
At what age should you first get your cholesterol checked? Cardiologist reveals: 'If you have a strong family history…'
Cholesterol is a type of lipid that your body needs to function. It forms part of your cell membranes, helps your liver make bile and serves as a building block for hormones. However, the problem arises when you have high levels of LDL cholesterol in your blood. This can lead to an increased risk of heart disease. Therefore, early detection is important, as it can often lead to you taking up life-changing measures. Most people check their cholesterol only when they have a problem. But the question is – when should one check their cholesterol for the first time?(Image by Freepik) Also Read | Cardiothoracic surgeon explains why young people are at risk of heart attack, cardiac arrest; can it be prevented? So, when should you get your cholesterol checked? What is the correct age to get it done for the first time? In an Instagram video post on July 22, Dr Naveen Bhamri, MD, DM (cardiology), revealed the right age to get your cholesterol checked for the first time. He wrote, 'Most people check their cholesterol only when they have a problem…But the question is – when should one check their cholesterol for the first time?' Let's find out what the doctor said. At what age should you first check your cholesterol levels? According to the cardiologist, the general recommendation suggests that a person should get their cholesterol checked at the age of 20 years, and it should be done with a fasting lipid profile. What if the data comes back normal? He said that if your tests show a normal number, then you should repeat the tests after 4-6 years. If you have a strong family history of heart disease, then get your cholesterol checked as early as possible. (Pexels) In case of high-risk patients… However, the story changes if you are a high-risk patient or have a family history. The cardiologist stressed that if you come under the high-risk category, for instance, you have a strong history of heart disease in your family, you have diabetes, you have high blood pressure, you are obese, you smoke regularly, you have PCOS (polycystic ovary syndrome), or you lead a sedentary lifestyle, then you should get your cholesterol checked as early as possible. He added that Indian guidelines say that one should get their first lipid profile done as early as the age of 12 years if they are obese and have a strong family history. 'So, lifestyle changes at an early age can prevent heart disease later,' Dr Bhamri added in the end. Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Hans India
an hour ago
- Hans India
Indian scientists develop new approach for treatment of liver cirrhosis
New Delhi: A team of Indian scientists has found a new way to treat liver cirrhosis, by targeting the lymphatic vessels in the liver and intestine that fail in case of cirrhosis. Chronic liver disease can progress from mild disease to fibrosis to cirrhosis (also known as scarring). Cirrhosis is accompanied by the distortion of both blood and lymphatic vessels in the liver and the intestine. Patients with advanced cirrhosis often develop complications like fluid accumulation in the abdomen. A team of scientists from the Institute of Liver and Biliary Sciences (ILBS), New Delhi, and National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, focussed on improving the drainage capacity of lymphatic vessels in the liver and intestine by using nanocarriers filled with a powerful protein called VEGF-C. 'Vascular endothelial growth factor-C (VEGF-C) is a key pro-lymphangiogenic factor that activates lymphangiogenesis or new lymphatic vessel growth. It does this through binding to a cell membrane tyrosine kinase receptor, vascular endothelial growth factor receptor-3 (VEGFR-3), the activation of which is essential for the growth and development of new lymphatic vessels,' said the researchers. The team probed the therapeutic efficacy of VEGF-C in ameliorating gut lymphatic dysfunction and improving lymph drainage. Owing to the hydrophilicity, short half-life, and systemic side effects of VEGF-C, the team led by Dr Subham Banerjee from NIPER Guwahati first focused on the development of VEGF-C encapsulated reverse micelle-based nanocarriers, which specifically bind to VEGFR-3 homodimers. Next, the ILBS team, led by Dr Savneet Kaur, tested the developed VEGF-C nanocarriers extensively in animal models of advanced cirrhosis and portal hypertension. The developed molecule was delivered via the oral route to ensure its gut lymphatic vessel uptake in the animal models. The team showed that VEGF-C nanocarriers significantly increased mesenteric lymph drainage, which reduced ascites. Importantly, the treatment also led to an attenuation of the portal pressures, improved cytotoxic T-cell immunity in mesenteric lymph nodes, and reduced local and systemic bacterial load. The research, published in the JHEP Reports journal, is the first to highlight that therapeutic lymphangiogenesis with VEGF-C is a promising treatment for reconstructing the fragmented lymphatic network and restoring lymphatic function and drainage in advanced cirrhosis.
Time of India
3 hours ago
- Time of India
Re-skilling techies, compute capacity & geopolitics in focus for second IndiaAI report
Academy Empower your mind, elevate your skills Jobs displacement due to adoption of artificial intelligence , re-skilling of the tech workforce, raising compute power and addressing geopolitical challenges are some of the issues that are expected to be among the main agendas ahead of the government as it prepares for the second edition of the IndiaAI report , officials report is planned to be readied before the key AI Impact Summit that India will chair in New Delhi in February 2026. Requests for feedback submission will soon go out to all central ministries, autonomous bodies as well as state governments, officials at the Ministry of Electronics and Information Technology in October 2023, the first IndiaAI report had laid out the full fulcrum of India's AI aspirations, with detailed inputs from seven working groups. These had recommended the setting up of 3 AI centres of excellence, development of large, multimodal AI foundation models trained on Indian languages and datasets, and driving cross-sector development in areas like health, agriculture, education and governance through AI."The previous report had laid out the foundational strategy and roadmap for India's national approach to artificial intelligence. The next one is planned to build on it to further fine tune targets to meet the goals under the Viksit Bharat 2047 initiative," an official the approval of the IndiaAI Mission, the government had allocated Rs 10,300 crore over five years beginning March 2024 to strengthen AI capabilities. The upcoming report may call for augmenting that amount considering the central position that AI has acquired in innovation and governance since then, he government wants solutions to emerge for large-scale re-skilling of the technological workforce, much of which in India's IT industry remains anxious of retrenchments due to AI. Similar to last time, senior executives from the private sector and academicians are expected to be part of the working groups that will give recommendations for the computing power would also be a key focus, people in the know said. While the government had initially targeted the development of a high-end common computing facility equipped with 10,000 graphics processing units (GPUs), India has successfully overshot the mark by empanelling 34,333 GPUs through the IndiaAI Compute platform . But the government is wary of export controls on critical hardware being placed by foreign governments, specifically the the previous Joe Biden administration's Artificial Intelligence Diffusion Framework, the US had placed India among Tier-2 countries with a volume cap of 50,000 H100-equivalent GPUs through 2027. Under Donald Trump, US' new AI policy has called for exporting the full US AI technology stack to 'allied nations' willing to join America's AI alliance, but also stresses on denying foreign adversaries access to US compute power citing geostrategic competition and national security. These two categories are not defined, and India would need to quickly find its feet, an official said."This and other geopolitical challenges such as the rapidly evolving AI power dynamics beyond nations have pushed the government to hold the summit in India next year,' this official said. 'It will build on the 2025 AI Action Summit in Paris co-chaired by Prime Minister Narendra Modi. It will showcase India's emerging leadership in creating consensus for global AI governance frameworks ."
